Camp-Sorrell D
University of Alabama Hospital at Birmingham, USA.
J Intraven Nurs. 1998 Jul-Aug;21(4):232-9.
Vesicant extravasation is a rare adverse reaction that occurs with vesicant chemotherapeutic agents. The result of an extravasation is distressing to the nurse and patient because significant pain, tissue necrosis, and loss of function at the site of injury can result. Although numerous studies have been conducted on vesicant management, controversies still exist concerning the optimal management procedures. However, it is clear that the most effective key to management of extravasation is prevention. Standards of practice provide the basis for preventing an extravasation, with the outcome being no occurrence of extravasation.
发泡剂外渗是使用发泡剂化疗药物时发生的一种罕见不良反应。外渗的后果令护士和患者都感到痛苦，因为损伤部位可能会出现剧痛、组织坏死和功能丧失。尽管已经针对发泡剂处理开展了大量研究，但关于最佳处理程序仍存在争议。然而，很明显，处理外渗最有效的关键在于预防。实践标准为预防外渗提供了依据，目标是不发生外渗。
